EN DE
STOCK COMPARISON

CareDx vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how CareDx (CDNA) and Thermo Fisher Scientific (TMO) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: CareDx trades at $46.69 versus a fair value of $9.85 (-79%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
CareDx
CDNA · USD · Health Care
-79%
upside to fair value
overvalued
Price$46.69
Fair Value$9.85
Quality68/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$594
Fair Value$308
Quality63/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

CareDxThermo Fisher Scientific
Valuation
—P/E (TTM)29.5×
3.06×P/S (TTM)4.41×
4.17×P/B3.74×
—EV/EBITDA20.0×
—PEG1.74×
—Dividend yield0.3%
—Dividend per share$1.76
Profitability
-2%Net margin15%
2%Operating margin18%
-2%Return on equity14%
-2%Return on assets5%
Growth
39%Revenue growth (YoY)6%
5.7%Avg. growth/yr (3Y)-0.3%
14.6%Avg. growth/yr (5Y)6.7%
Balance & size
0.06×Debt / equity0.67×
$1BMarket cap$199B
mixedGrowth qualityhealthy

Even match: 5 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

CareDxof which business quality 69 · market factors 70 Thermo Fisher Scientificof which business quality 60 · market factors 65
ProfitabilityMargins and returns on capital today
33
43
Quality GrowthAre margins and returns improving?
62
31
CashflowEarnings quality: real cash, not paper profit
60
62
Fin. StrengthBalance sheet, leverage, solvency risk
87
60
InvestmentDisciplined investing over empire-building
100
79
Low VolatilityCalm price path (market factor)
0
68
MomentumPrice trend over the last 3–12 months (market factor)
100
58
52W MomentumDistance to the 52-week high (market factor)
100
72
Net IssuanceBuybacks instead of dilution
92
97

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

CareDx

DCF Models$14.80
Dividend Discount$0.56
Multiples$10.00
Asset-Based$3.93
Growth DCF$15.80

9 of 9 models see the stock below the current price.

Thermo Fisher Scientific

DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

CareDx
Bear $7.12Fair Value $9.85Bull $12.58
$46.69 = current price (white tick)
Thermo Fisher Scientific
Bear $175Fair Value $308Bull $385
$594 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

CareDx · Health Care

Quality score68 · Top 25%
Fair value upside-79% · bottom 25%

Thermo Fisher Scientific · Health Care

Quality score63 · above median
Fair value upside-48% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: CareDx trades at $46.69 versus a fair value of $9.85 (-79%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).

CareDx has the higher quality score (68/100).

See the full analysis →
CareDx · Thermo Fisher Scientific

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to CareDx

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Thermo Fisher Scientific

UnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AstraZenecaUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.